“Supergirl” opened to $37.1 million this past weekend, and TheWrap reports it is now on track to lose Warner Bros. Discovery at least $85 million during its theatrical run once marketing costs are factored in. The key problem is simple and brutal: the movie needs to perform far above its opening to justify the spend.

Here is the break-even math the trade is pointing to. TheWrap says “Supergirl” has a reported production budget of $170 million, and insiders said the film needs to hit at least $315 million worldwide just to break even. That sets up a mismatch with what audiences actually delivered, because opening weekend underwhelmed against both expectations and comparable superhero underperformance. TheWrap notes “Morbius,” Sony/Marvel’s 2022 misfire, started with $39 million domestic and $84 million domestically, and it quickly lost audience interest, grossing just $167 million worldwide.

This is not just a film story. It is an underwriting story, and underwriting is what CFOs, boards, and studio finance teams obsess over because it determines what happens next: whether you greenlight more “brand expansion” or you revert to safer, already-proven IP. The source describes “Supergirl” as the second in James Gunn and Peter Safran’s new DC universe of movies. That matters because a reboot is not meant to be a one-off. It is meant to reset the franchise’s momentum, and momentum comes from repeatable audience behavior, not one-time curiosity.

The report ties the box office issue to reception. “Supergirl” has a 54% score on Rotten Tomatoes, and it earned a B- CinemaScore from the opening weekend crowd. Those numbers translate into an uncomfortable dynamic: even if marketing can pull in first-week curiosity, sustained demand typically depends on reviews and audience satisfaction. When that satisfaction is merely “okay-ish” rather than hot, the opening can become a ceiling instead of a springboard.

Then there is the incentives layer. The franchise is being built through DC Studios, which is overseen by Gunn and Safran. The source notes that after “Superman” helped get Gunn and Safran’s DC Universe reboot off to a good start with a $618 million run last year, “Supergirl” shows “they and their DC Studios team have work to do” to build mass interest in films based on characters that are not always first-choice household names like Supergirl. This is the core second-order question for executives: can the studio turn “deep cut” characters into must-see events, or will audiences require either stronger critical buy-in or bigger event marketing than the current formula delivers?

And while studios do not publish their internal boardroom models to the public, the outcome being described has clear capital implications. If a reported $170 million production budget already requires $315 million worldwide to break even, marketing costs can push the studio into a larger-than-budget loss even without a dramatic catastrophe. TheWrap’s framing says the film is on track to lose at least $85 million after marketing is included. In plain terms, that is a signal that the financial risk is not limited to production. It extends through the whole theatrical lifecycle, where the biggest cost is often the campaign required to keep demand alive.

Safran addressed the situation in a statement to The New York Times, according to TheWrap. The source quotes co-chairman and co-chief executive of DC Studios saying he is confident in the course he and Gunn have set for the franchise, and that “While ‘Supergirl’ didn’t meet our box office expectations, it’s just one component of a broader, long-term strategy at DC Studios that we remain confident in.” That kind of message is designed for boards and internal stakeholders as much as for the press. It is meant to prevent a single quarter’s disappointment from rewriting the strategy that has already been scheduled, financed, and marketed.

Looking ahead, the slate is doing what slates do: it does not stop because one release stumbled. DC’s next tentpole film will be “Man of Tomorrow,” a “Superman” sequel coming next summer, written and directed by Gunn. That will be followed by “The Batman: Part II” starring Robert Pattinson, hitting theaters in October 2027. Even without inventing outcomes, the implication is obvious for executives who manage pipeline risk: the studio needs its next projects to restore confidence, because the market tends to price franchises based on the latest evidence of audience traction.